Cargando…

Association between serum S100A9 levels and liver necroinflammation in chronic hepatitis B

BACKGROUND: S100A9 protein, which is recently classified as a novel damage associated molecular pattern, is released from stressed cells undergoing necrosis or secreted by living cells undergoing a stress that act as endogenous danger signal associated with infection, tissue damage and cancer. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Rui, Zhang, Yuhong, Xiang, Yu, Tang, Yishu, Cui, Fang, Cao, Ju, Zhou, Lan, You, Yan, Duan, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883874/ https://www.ncbi.nlm.nih.gov/pubmed/29615081 http://dx.doi.org/10.1186/s12967-018-1462-2

Ejemplares similares

Association between serum sphingolipids and necroinflammation of liver tissue pathology in chronic hepatitis B
por: Ren, Yan, et al.
Publicado: (2022)

M2-like macrophages exert hepatoprotection in acute-on-chronic liver failure through inhibiting necroptosis-S100A9-necroinflammation axis
por: Bai, Li, et al.
Publicado: (2021)

Factors associated with significant liver necroinflammation in chronic hepatitis B patients with cirrhosis
por: Chen, Sheng-Sen, et al.
Publicado: (2016)

Exploring the Diagnostic Potential of Serum Golgi Protein 73 for Hepatic Necroinflammation and Fibrosis in Chronic HCV Infection with Different Stages of Liver Injuries
por: Qian, Xiangjun, et al.
Publicado: (2019)

Plasma Sphingolipids as Potential Indicators of Hepatic Necroinflammation in Patients with Chronic Hepatitis C and Normal Alanine Aminotransferase Level
por: Li, Jun-Feng, et al.
Publicado: (2014)

Death and fire—the concept of necroinflammation
por: Linkermann, Andreas
Publicado: (2018)

Serum MicroRNA-21 as Marker for Necroinflammation in Hepatitis C Patients with and without Hepatocellular Carcinoma
por: Bihrer, Verena, et al.
Publicado: (2011)

Serum Golgi Protein 73 as a Potential Biomarker for Hepatic Necroinflammation in Population with Nonalcoholic Steatohepatitis
por: Wang, Leijie, et al.
Publicado: (2020)

Discordance between Liver Biopsy and FibroScan® in Assessing Liver Fibrosis in Chronic Hepatitis B: Risk Factors and Influence of Necroinflammation
por: Kim, Seung Up, et al.
Publicado: (2012)

Identification of circulating microRNAs as potential biomarkers for hepatic necroinflammation in patients with autoimmune hepatitis
por: Saeki, Chisato, et al.
Publicado: (2022)

Neonatal obstructive nephropathy induces necroptosis and necroinflammation
por: Popper, Bastian, et al.
Publicado: (2019)

A Prominent Role of Interleukin-18 in Acetaminophen-Induced Liver Injury Advocates Its Blockage for Therapy of Hepatic Necroinflammation
por: Bachmann, Malte, et al.
Publicado: (2018)

Liver Stiffness Measurement Can Reflect the Active Liver Necroinflammation in Population with Chronic Liver Disease: A Real-world Evidence Study
por: Wang, Leijie, et al.
Publicado: (2019)

RIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD
por: Chen, Hui, et al.
Publicado: (2018)

Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19
por: Tomar, Bhawna, et al.
Publicado: (2020)

Types of necroinflammation, the effect of cell death modalities on sterile inflammation
por: Mázló, Anett, et al.
Publicado: (2022)

Circulating MiRNA-122 Levels Are Associated with Hepatic Necroinflammation and Portal Hypertension in HIV/HCV Coinfection
por: Jansen, Christian, et al.
Publicado: (2015)

SAP130 released by damaged tubule drives necroinflammation via miRNA-219c/Mincle signaling in acute kidney injury
por: Lv, Lin-Li, et al.
Publicado: (2021)

Genetic disruption of NRF2 promotes the development of necroinflammation and liver fibrosis in a mouse model of HFE-hereditary hemochromatosis
por: Duarte, Tiago L., et al.
Publicado: (2016)

S-allylmercaptocysteine reduces carbon tetrachloride-induced hepatic oxidative stress and necroinflammation via nuclear factor kappa B-dependent pathways in mice
por: Xiao, Jia, et al.
Publicado: (2011)

Paving the way for precision medicine v2.0 in intensive care by profiling necroinflammation in biofluids
por: Vanden Berghe, Tom, et al.
Publicado: (2018)

Serum S100B Levels in Patients with Liver Cirrhosis and Hepatic Encephalopathy
por: Kim, Mo-Jong, et al.
Publicado: (2023)

Dapagliflozin Alleviates Renal Fibrosis by Inhibiting RIP1-RIP3-MLKL-Mediated Necroinflammation in Unilateral Ureteral Obstruction
por: Xuan, Mei Ying, et al.
Publicado: (2022)

S100A8-Mediated NLRP3 Inflammasome-Dependent Pyroptosis in Macrophages Facilitates Liver Fibrosis Progression
por: Liu, Yan, et al.
Publicado: (2022)

Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients
por: Sagnelli, Caterina, et al.
Publicado: (2017)

A murine cellular model of necroinflammation displays RAGE‐dependent cytokine induction that connects to hepatoma cell injury
por: Bachmann, Malte, et al.
Publicado: (2020)

Plasma S100A8 and S100A9 Are Strong Prognostic Factors for Hepatitis B Virus-Related Acute-on-Chronic Liver Failure
por: Zhang, Yao, et al.
Publicado: (2023)

Portulaca oleracea alleviates CCl(4)-induced acute liver injury by regulating hepatic S100A8 and S100A9
por: Qian, Aruna, et al.
Publicado: (2022)

Cell type-specific roles of NLRP3, inflammasome-dependent and -independent, in host defense, sterile necroinflammation, tissue repair, and fibrosis
por: Honda, Tamisa Seeko Bandeira, et al.
Publicado: (2023)

HBx-induced S100A9 in NF-κB dependent manner promotes growth and metastasis of hepatocellular carcinoma cells
por: Duan, Liang, et al.
Publicado: (2018)

Association of S100B polymorphisms and serum S100B with risk of ischemic stroke in a Chinese population
por: Lu, Yu-Lan, et al.
Publicado: (2018)

Serum alarmin S100A8/S100A9 levels and its potential role as biomarker in myocarditis
por: Müller, Irene, et al.
Publicado: (2020)

Serum Levels of S100A11 and MMP-9 in Patients with Epithelial Ovarian Cancer and Their Clinical Significance
por: Li, Wenjing, et al.
Publicado: (2021)

S100A8 and S100A9 Promote Apoptosis of Chronic Eosinophilic Leukemia Cells
por: Lee, Ji-Sook, et al.
Publicado: (2020)

S100A8 and S100A9 Are Associated with Colorectal Carcinoma Progression and Contribute to Colorectal Carcinoma Cell Survival and Migration via Wnt/β-Catenin Pathway
por: Duan, Liang, et al.
Publicado: (2013)

S100A8, S100A9 and S100A8/A9 heterodimer as novel cachexigenic factors for pancreatic cancer-induced cachexia
por: Liao, Wei-Chih, et al.
Publicado: (2023)

Elevated Serum S100A9 Indicated Poor Prognosis in Hepatocellular Carcinoma after Curative Resection
por: Meng, Jun, et al.
Publicado: (2019)

Decreased S100B expression in chronic liver diseases
por: Baik, Su Jung, et al.
Publicado: (2017)

Correction: S100A8 and S100A9 Are Associated with Colorectal Carcinoma Progression and Contribute to Colorectal Carcinoma Cell Survival and Migration via Wnt/β-Catenin Pathway
por: Duan, Liang, et al.
Publicado: (2013)

The Significance of Serum S100A9 and TNC Levels as Biomarkers in Colorectal Cancer
por: Zhou, Minze, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_36n96q4m4cv3nmfrnlk83dp0a1